Header Logo

Abir Kanaan

Concepts (160)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anticoagulants
8
2018
392
1.870
Why?
Venous Thromboembolism
3
2018
146
1.350
Why?
Pharmacy Service, Hospital
4
2020
17
0.990
Why?
Drug-Related Side Effects and Adverse Reactions
3
2013
127
0.640
Why?
Patient Discharge
4
2015
408
0.630
Why?
Antipsychotic Agents
5
2015
281
0.560
Why?
Postthrombotic Syndrome
1
2014
3
0.550
Why?
Stockings, Compression
1
2014
3
0.550
Why?
Platelet Aggregation Inhibitors
2
2013
216
0.510
Why?
Nursing Homes
8
2015
531
0.510
Why?
Fellowships and Scholarships
2
2015
60
0.490
Why?
Hypolipidemic Agents
1
2012
35
0.460
Why?
Warfarin
4
2014
101
0.460
Why?
Primary Prevention
1
2012
114
0.430
Why?
Antihypertensive Agents
1
2012
150
0.420
Why?
Thrombosis
2
2010
188
0.410
Why?
Stroke
3
2013
858
0.410
Why?
Pipecolic Acids
1
2010
2
0.410
Why?
Hemorrhage
5
2018
217
0.410
Why?
Antithrombins
1
2010
14
0.400
Why?
Thrombocytopenia
1
2010
49
0.390
Why?
Heparin
1
2010
106
0.380
Why?
Education, Pharmacy, Graduate
1
2009
4
0.380
Why?
Students, Pharmacy
1
2009
7
0.380
Why?
Medication Errors
3
2021
106
0.340
Why?
Randomized Controlled Trials as Topic
4
2018
482
0.340
Why?
Homes for the Aged
4
2014
147
0.340
Why?
Pharmacists
2
2021
86
0.330
Why?
Aspirin
3
2013
176
0.330
Why?
Humans
29
2021
48588
0.290
Why?
Cardiovascular Diseases
1
2012
708
0.280
Why?
Dementia
3
2015
174
0.250
Why?
Drug Utilization
3
2015
221
0.230
Why?
Continuity of Patient Care
2
2014
164
0.220
Why?
Medication Systems
1
2021
18
0.220
Why?
Patient Readmission
2
2015
345
0.210
Why?
Pharmacy and Therapeutics Committee
1
2020
3
0.210
Why?
Decision Support Systems, Clinical
2
2011
62
0.210
Why?
Electronic Health Records
2
2014
273
0.200
Why?
Patient Safety
2
2020
185
0.200
Why?
Aged
11
2021
10798
0.190
Why?
Premedication
1
2018
17
0.170
Why?
Male
13
2021
23090
0.170
Why?
Rivaroxaban
2
2014
13
0.170
Why?
Dabigatran
2
2014
17
0.170
Why?
Pyridones
2
2014
26
0.170
Why?
Pyrazoles
2
2014
60
0.160
Why?
Female
13
2021
26138
0.160
Why?
Connecticut
5
2015
82
0.160
Why?
Inappropriate Prescribing
2
2014
47
0.150
Why?
Nursing Staff
2
2013
41
0.150
Why?
Transitional Care
1
2015
14
0.150
Why?
Off-Label Use
1
2015
13
0.150
Why?
Quality of Health Care
3
2015
470
0.150
Why?
Societies, Pharmaceutical
1
2015
3
0.140
Why?
Internship, Nonmedical
1
2015
2
0.140
Why?
Medical Informatics
1
2015
64
0.140
Why?
Aged, 80 and over
8
2021
4210
0.140
Why?
Marketing of Health Services
1
2015
23
0.140
Why?
Skilled Nursing Facilities
1
2015
75
0.140
Why?
Practice Patterns, Physicians'
3
2015
681
0.140
Why?
Time Factors
2
2013
3188
0.140
Why?
Models, Organizational
1
2015
86
0.130
Why?
Consultants
1
2014
12
0.130
Why?
Office Visits
1
2014
41
0.130
Why?
Dipyridamole
1
2013
22
0.130
Why?
Medical Staff
1
2013
17
0.130
Why?
Drug Monitoring
2
2012
97
0.130
Why?
Administrative Personnel
1
2013
32
0.130
Why?
Hospitals, Veterans
1
2015
147
0.130
Why?
Administration, Oral
1
2014
292
0.130
Why?
Research
1
2015
185
0.120
Why?
Ticlopidine
1
2013
61
0.120
Why?
Secondary Prevention
1
2013
123
0.120
Why?
Ramipril
1
2012
1
0.120
Why?
Hydrochlorothiazide
1
2012
2
0.120
Why?
Long-Term Care
2
2011
163
0.120
Why?
Atenolol
1
2012
7
0.120
Why?
Psychiatry
1
2014
103
0.120
Why?
Simvastatin
1
2012
21
0.120
Why?
Ambulatory Care Information Systems
1
2012
10
0.120
Why?
Drug Combinations
1
2012
121
0.110
Why?
Ambulatory Care
1
2014
270
0.110
Why?
Drug Costs
1
2011
53
0.110
Why?
Medical Order Entry Systems
1
2011
45
0.110
Why?
Practice Guidelines as Topic
1
2015
597
0.110
Why?
Data Interpretation, Statistical
2
2013
189
0.110
Why?
Renal Insufficiency, Chronic
1
2011
69
0.110
Why?
Clinical Protocols
1
2011
123
0.100
Why?
Ambulatory Care Facilities
1
2010
94
0.100
Why?
Psychotropic Drugs
1
2010
72
0.100
Why?
Arginine
1
2010
107
0.090
Why?
Guidelines as Topic
1
2010
148
0.090
Why?
Sulfonamides
1
2010
118
0.090
Why?
Clinical Competence
1
2013
533
0.090
Why?
Severity of Illness Index
1
2013
1154
0.090
Why?
Pharmaceutical Preparations
1
2010
109
0.090
Why?
Safety Management
1
2010
131
0.090
Why?
Education, Pharmacy
1
2009
14
0.090
Why?
Medication Therapy Management
1
2009
26
0.090
Why?
Primary Health Care
1
2014
549
0.090
Why?
Drug Prescriptions
1
2010
176
0.090
Why?
Hospitalization
2
2021
1063
0.090
Why?
Heparin, Low-Molecular-Weight
1
2007
24
0.090
Why?
Antineoplastic Agents
1
2013
540
0.080
Why?
Atrial Fibrillation
1
2013
532
0.080
Why?
Communication
1
2011
429
0.080
Why?
Pulmonary Embolism
1
2007
159
0.070
Why?
Odds Ratio
1
2007
763
0.070
Why?
Neoplasms
1
2013
985
0.060
Why?
Information Dissemination
2
2015
102
0.060
Why?
International Normalized Ratio
2
2012
36
0.060
Why?
Massachusetts
2
2021
2014
0.060
Why?
Pilot Projects
2
2015
716
0.050
Why?
Middle Aged
4
2021
13418
0.050
Why?
Organizational Culture
1
2020
98
0.050
Why?
Treatment Outcome
1
2007
3797
0.040
Why?
Cross-Sectional Studies
2
2015
2032
0.040
Why?
Half-Life
1
2015
62
0.040
Why?
Schools, Pharmacy
1
2015
5
0.040
Why?
Health Facility Size
1
2015
17
0.040
Why?
Workload
1
2015
99
0.030
Why?
Cluster Analysis
1
2015
236
0.030
Why?
Efficiency, Organizational
1
2015
90
0.030
Why?
Databases, Bibliographic
1
2013
8
0.030
Why?
beta-Alanine
1
2013
7
0.030
Why?
Dose-Response Relationship, Drug
1
2015
760
0.030
Why?
Evidence-Based Practice
1
2013
59
0.030
Why?
Morpholines
1
2013
66
0.030
Why?
Thiophenes
1
2013
38
0.030
Why?
Evidence-Based Medicine
1
2015
361
0.030
Why?
Benzimidazoles
1
2013
49
0.030
Why?
Interviews as Topic
1
2015
415
0.030
Why?
Poisson Distribution
1
2012
51
0.030
Why?
Health Communication
1
2013
28
0.030
Why?
Qualitative Research
1
2015
393
0.030
Why?
Needs Assessment
1
2013
155
0.030
Why?
Precision Medicine
1
2013
84
0.030
Why?
Drug Therapy, Combination
1
2013
369
0.030
Why?
Ontario
1
2011
36
0.030
Why?
Double-Blind Method
1
2013
548
0.030
Why?
United States
2
2015
6100
0.030
Why?
Organizational Case Studies
1
2011
42
0.030
Why?
Cost Savings
1
2011
45
0.030
Why?
Chronic Disease
1
2015
669
0.030
Why?
Regression Analysis
1
2012
463
0.030
Why?
Telephone
1
2011
112
0.030
Why?
Prevalence
1
2014
1108
0.030
Why?
Parents
1
2013
258
0.020
Why?
New England
1
2010
244
0.020
Why?
Attitude of Health Personnel
1
2013
488
0.020
Why?
Follow-Up Studies
1
2014
1922
0.020
Why?
Quality Assurance, Health Care
1
2011
240
0.020
Why?
Cohort Studies
1
2012
2059
0.020
Why?
Risk Assessment
1
2013
1571
0.020
Why?
Prospective Studies
1
2012
2478
0.020
Why?
Surveys and Questionnaires
1
2013
2237
0.020
Why?
Risk Factors
1
2013
4204
0.020
Why?
Child
1
2013
3658
0.020
Why?
Retrospective Studies
1
2014
4404
0.020
Why?
Kanaan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (160)
Explore
_
Co-Authors (14)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_